Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors

International Journal of Cancer

Volumn 113, Issue 3, 2005, Pages 471-474

  Spangler, E ^a   Zeigler Johnson, C M ^a   Malkowicz, S B ^a,b   Wein, A J ^a,b   Rebbeck, T R ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Family history; Prognosis; Prostate cancer; Tumor characteristics

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMICAL ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; EXPERIENCE; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; RISK; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; CASE-CONTROL STUDIES; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SEMINAL VESICLES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 11144261692     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20578     Document Type: Article

References (20)

1. Stanford JL, Stephenson RA, Coyle LM, Cerhan J, Correa R, Eley JW, Gilliland F, Hankey B, Kolonel LN, Kosary C, Ross R, Severson R, et al. Prostate cancer trends 1973-1995. SEER Program, National Cancer Institute. NIH Pub. No. 99-4543. Bethesda, MD: NIH, 1999.
2. Lichtenstein P, Holm NV, Verkasalo PK. Environmental and heritable factors in the causation of cancer. N Engl J Med 2000;343:78-85.
3. Goode EL, Stanford JL, Peters MA, Janer M, Gibbs M, Kolb S, Bedzioch MD, Hood L, Ostrander EA, Jarvik GP. Clinical characteristics of prostate cancer in an analysis of linkage for four putative susceptibility loci. Clin Cancer Res 2001;7:2739-49.
4. Stanford J, Ostrander E. Familial prostate cancer. Epidemiol Rev 2001;23:19-23.
5. Ostrander E, Stanford J. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 2000;67:1367-75.
6. Kupelian PA, Kupelian VA, Witte JS, Macklis R, Klein EA. Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. J Clin Oncol 1997;15:1478-80.
7. Carter BS, Bova GS, Beaty TH. Hereditary prostate cancer: epidemiological and clinical features. J Urol 1993;150:799-802.
8. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI. Prostate cancer: pathological features of hereditary prostate cancer. J Urol 1995;153:987-92.
9. Keetch DW, Humphrey PA, Smith DS, Stahl D, Catalona WI. Clinical and pathological features of hereditary prostate cancer. J Urol 1996;155:1841-42.
10. Bauer JJ, Srivastava S, Connelly RR. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy. Urology 1998;51:970-6.
11. Steinberg, G.D., Carter, B.S., and Beaty, T.H.: Family history and risk of prostate cancer. Prostate, 1990;17:337-47.
12. Aprikian AG, Bazinet N, Plante M. Family history and risk of prostate carcinoma in a high risk group of urological patients. J Urol 1995;154:404-6.
13. Norrish AE, McRae CU, Cohen RJ, Jackson RT. A population-based study of clinical and pathological prognostic characteristics of men with familial and sporadic prostate cancer. BJU Int 1999;84:311-15.
14. Kupelian PA, Klein EA, Witte JS, Kupelian VA, Suh JH. Familial prostate cancer: a different disease? J Urol 1997;158:2197-201.
15. Rodriguez C, Calle E, Miracle-McMahill H, Tatham L, Wingo P, Thun M, Heath C. Family history and risk of fatal prostate cancer. Epidemiology 1997;8:653-7.
16. Bratt O, Kristoffersson U, Olsson H, Lundgren R. Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor. Eur Urol 1998;34:19-24.
17. Bratt O, Damber M, Emanuelsson M, Gronberg H. Hereditary prostate cancer: clinical characteristics and survival. J Urol 2002;167:2423-6.
18. Bova GS, Partin AW, Isaacs SD, Carter BS, Beaty TL, Isaacs WB, Walsh PC. Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. J Urol 1998;160:660-3.
19. Gronberg H, Damber L, Tavelin B, Damber JE. No difference in survival between sporadic familial and hereditary prostate cancer. Br J Urol 1998;82:564-7.
20. Kotsis SV, Spencer SL, Peyser PA, Montie JE, Cooney KA. Early onset prostate cancer: predictors of clinical grade. J Urol 2002;167:1659-63.